CVS brings back coverage for Lilly's obesity drug Zepbound - Reuters
CVS Caremark is restoring coverage of Lilly's Zepbound after Lilly cut pricing, potentially opening access to millions of insured Americans. LLY has already ripped 4.1% on the news, raising the question of whether the move is fully priced or sets up a continued re-rating.
What happened
CVS Caremark is restoring coverage of Lilly's Zepbound after Lilly cut pricing, potentially opening access to millions of insured Americans.
The read · May 28
Fade the LLY spike near-term — stock is up 4% on news already digested by the market, insiders are selling, and consensus is already Buy-heavy with no new price-target catalyst to drive further re-rating.
Wrong if
A formal CVS formulary volume disclosure or an unexpected Medicare/PBM coverage domino (e.g., Express Scripts follows) could extend the rally and invalidate the fade quickly.
CoverageSource: Google News · Published here THU, MAY 28 · 4:02 PM ET · the only report in this recordHow this is decided →
The chart · LLYTradingView · third-party feed, not the Wire’s licensed closes
🔒 Click to interact · scroll moves the page
The story1 min read
The read, in fullWhy it matters
LLY is up 4.1% on a distribution deal that was well-telegraphed (Bloomberg, CNBC, Reuters all covered it yesterday), meaning the move is largely a catch-up trade rather than new information. Consensus is already 11 Strong Buy / 19 Buy with no fresh price target to anchor further upside, and insiders have been net sellers (0 buys, 2 sells last 30 days). The Phase 1b Verve-102 headline is unrelated to the GLP-1 thesis and unlikely to sustain the gap. A mean-reversion fade back toward flat on the week is the cleaner trade given the crowded positioning.
The arc● Open · no developments yet
· Published
The read above, as written. kept as written
Next · what would move this
5-10 trading days. Follow to be told when one lands.
Receipts
Google News — the original4:02 PM
Research, not advice.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →